Growth Metrics

Penumbra (PEN) Shares Outstanding (Diluted Average) (2014 - 2026)

Penumbra (PEN) reported Shares Outstanding (Diluted Average) of $39.5 million for Q1 2026, up 0.97% year-over-year from $39.2 million in Q1 2025, and up 0.64% on a QoQ basis from $39.3 million in Q4 2025.

Penumbra (PEN) has 13 years of Shares Outstanding (Diluted Average) data on file, last reported at $39.5 million in Q1 2026.

  • Quarterly Shares Outstanding (Diluted Average) rose 0.97% year-over-year to $39.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $39.5 million (up 0.97% YoY) and the FY2025 annual result came in at $39.3 million, changed 0.06% from the prior year.
  • Shares Outstanding (Diluted Average) grew to $39.5 million in Q1 2026 per PEN's latest filing, from $39.3 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $39.5 million in Q1 2026 and bottomed at $37.8 million in Q2 2022.
  • The 5-year median for Shares Outstanding (Diluted Average) is $39.2 million (2025), against an average of $38.9 million.
  • The widest annual swing landed in 2023, when Shares Outstanding (Diluted Average) grew 3.66%; it then retreated 1.22% in 2024.
  • Tracing PEN's Shares Outstanding (Diluted Average) over 5 years: stood at $37.8 million in 2022, then increased by 3.63% to $39.2 million in 2023, then gained by 0.13% to $39.3 million in 2024, then climbed by 0.06% to $39.3 million in 2025, then advanced by 0.64% to $39.5 million in 2026.
  • Per Business Quant, the three latest PEN Shares Outstanding (Diluted Average) figures stand at $39.5 million (Q1 2026), $39.3 million (Q4 2025), and $39.3 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares (Diluted Avg.) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 1.75 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 386.50 Mn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 1.29 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 1.50 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 580.70 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 393.60 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 457.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 Penumbra 12.52 Bn 11.91 Bn 253.41 Mn 39.54 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 39.54 Mn
Dec 31, 2025 39.29 Mn
Sep 30, 2025 39.25 Mn
Jun 30, 2025 39.25 Mn
Mar 31, 2025 39.16 Mn
Dec 31, 2024 39.27 Mn
Sep 30, 2024 38.71 Mn
Jun 30, 2024 38.79 Mn
Mar 31, 2024 39.39 Mn
Dec 31, 2023 39.22 Mn
Sep 30, 2023 39.18 Mn
Jun 30, 2023 39.15 Mn
Mar 31, 2023 39.08 Mn
Dec 31, 2022 37.84 Mn
Sep 30, 2022 37.92 Mn
Jun 30, 2022 37.77 Mn
Mar 31, 2022 38.71 Mn
Dec 31, 2021 37.88 Mn
Sep 30, 2021 37.61 Mn
Jun 30, 2021 37.58 Mn
Mar 31, 2021 37.53 Mn
Dec 31, 2020 35.77 Mn
Sep 30, 2020 36.21 Mn
Jun 30, 2020 35.40 Mn
Mar 31, 2020 36.36 Mn
Dec 31, 2019 36.27 Mn
Sep 30, 2019 36.27 Mn
Jun 30, 2019 36.21 Mn
Mar 31, 2019 36.21 Mn
Dec 31, 2018 36.09 Mn
Sep 30, 2018 34.25 Mn
Jun 30, 2018 36.12 Mn
Mar 31, 2018 35.92 Mn
Dec 31, 2017 35.32 Mn
Sep 30, 2017 35.66 Mn
Jun 30, 2017 33.22 Mn
Mar 31, 2017 31.61 Mn
Dec 31, 2016 33.48 Mn
Sep 30, 2016 33.76 Mn
Jun 30, 2016 33.31 Mn
Mar 31, 2016 33.02 Mn
Dec 31, 2015 14.22 Mn
Sep 30, 2015 10.19 Mn
Jun 30, 2015 5.10 Mn
Mar 31, 2015 7.19 Mn
Dec 31, 2014 4.61 Mn
Sep 30, 2014 4.69 Mn
Jun 30, 2014 6.87 Mn
Mar 31, 2014 6.71 Mn